Literature DB >> 27656170

Response: Commentary: Zika Virus: the Latest Newcomer.

Juan-Carlos Saiz1, Ana B Blázquez1, Nereida Jiménez De Oya1, Teresa Merino-Ramos1, Miguel A Martín-Acebes1, Estela Escribano-Romero1, Ángela Vázquez-Calvo1.   

Abstract

Entities:  

Keywords:  Flavivirus; Guillain-Barre syndrome; Zika virus (ZIKV); communicable diseases; surveillance

Year:  2016        PMID: 27656170      PMCID: PMC5013042          DOI: 10.3389/fmicb.2016.01398

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


× No keyword cloud information.
We really appreciate Craig et al. (2016) for their commended to our contribution to the current knowledge about Zika Virus (ZIKV), and their comments to the possible relationship between Guillain-Barre syndrome (GBS) and ZIKV infection (Saiz et al., 2016). Even more, we absolutely agree with their interpretations and recommendations pointing to the necessity of further research to accurately quantify the effect of enhanced surveillance related to ZIKV circulation and associated risks. In fact, we clearly stated in the abstract of our review (Saiz et al., 2016) and throughout the text, including our final remarks, that clarifying whether there is a causal link between ZIKV infection and GBS is a currently unavoidable goal. In this regard, recently, we have specifically addressed what it is currently known about ZIKV infections in relation with neurological manifestations (Blázquez and Saiz, in press), and stated that, beside the reported data pointing to a relationship between ZIKV infection and GBS, so far, a causal association has not been yet solidly established. GBS is a clinical syndrome of multiple autoimmune etiologies and the most common and severe acute paralytic neuropathy (van den Berg et al., 2014; Willison et al., 2016). In in many cases GBS appears to be associated with antecedent infectious diseases (Winner, 2001), and sporadic arboviral infections with dengue virus, DENV (Garg et al., 2015; Simon et al., 2016), West Nile virus, WNV (Sejvar, 2004), or chikungunya virus, CHIKV (Wielanek et al., 2007) have already been associated to GBS. In fact, Malone et al. (2016) have suggested that the concomitant regional increase in DENV and CHIKV infections may have contribute to the recently registered increase in GBS incidence. In any case, and beyond the considerable efforts carried out by the scientific community and the national and international health authorities focused on deciphering ZIKV infection and its consequences, sufficient resources should be allocated to provide the necessary tools to evaluate the potential mechanisms of ZIKV association to GBS.

Author contributions

All authors conceived the ideas presented in the article. J-CS led the drafting of the article with inputs from all other contributors. AV-C led the submission process.

Funding

This work was supported by grant ZIKA-BIO from INIA to J-CS, and AGL2014-56518-JIN from MINECO to MM, AV-C is a recipient of a “Contrato de formación postodoctoral” from MINECO. TM is a recipient of a “Formación de Personal Investigador (FPI)” pre-doctoral fellowship from INIA.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  11 in total

Review 1.  Guillain Barré syndrome.

Authors:  J B Winer
Journal:  Mol Pathol       Date:  2001-12

2.  Guillain-Barré syndrome complicating a Chikungunya virus infection.

Authors:  A C Wielanek; J De Monredon; M El Amrani; J C Roger; J P Serveaux
Journal:  Neurology       Date:  2007-11-27       Impact factor: 9.910

Review 3.  Guillain-Barré syndrome: pathogenesis, diagnosis, treatment and prognosis.

Authors:  Bianca van den Berg; Christa Walgaard; Judith Drenthen; Christiaan Fokke; Bart C Jacobs; Pieter A van Doorn
Journal:  Nat Rev Neurol       Date:  2014-07-15       Impact factor: 42.937

Review 4.  Guillain-Barré syndrome.

Authors:  Hugh J Willison; Bart C Jacobs; Pieter A van Doorn
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

Review 5.  Early Guillain-Barré Syndrome associated with acute dengue fever.

Authors:  O Simon; S Billot; D Guyon; M Daures; E Descloux; A C Gourinat; N Molko; M Dupont-Rouzeyrol
Journal:  J Clin Virol       Date:  2016-02-03       Impact factor: 3.168

6.  West Nile virus and "poliomyelitis".

Authors:  James J Sejvar
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

7.  Dengue-associated neuromuscular complications.

Authors:  Ravindra Kumar Garg; Hardeep Singh Malhotra; Amita Jain; Kiran Preet Malhotra
Journal:  Neurol India       Date:  2015 Jul-Aug       Impact factor: 2.117

Review 8.  Zika Virus: the Latest Newcomer.

Authors:  Juan-Carlos Saiz; Ángela Vázquez-Calvo; Ana B Blázquez; Teresa Merino-Ramos; Estela Escribano-Romero; Miguel A Martín-Acebes
Journal:  Front Microbiol       Date:  2016-04-19       Impact factor: 5.640

Review 9.  Zika Virus: Medical Countermeasure Development Challenges.

Authors:  Robert W Malone; Jane Homan; Michael V Callahan; Jill Glasspool-Malone; Lambodhar Damodaran; Adriano De Bernardi Schneider; Rebecca Zimler; James Talton; Ronald R Cobb; Ivan Ruzic; Julie Smith-Gagen; Daniel Janies; James Wilson
Journal:  PLoS Negl Trop Dis       Date:  2016-03-02

10.  Commentary: Zika Virus: the Latest Newcomer.

Authors:  Adam T Craig; Beverley J Paterson; David N Durrheim
Journal:  Front Microbiol       Date:  2016-06-28       Impact factor: 5.640

View more
  1 in total

1.  Infection of a French Population of Aedes albopictus and of Aedes aegypti (Paea Strain) with Zika Virus Reveals Low Transmission Rates to These Vectors' Saliva.

Authors:  Faustine Ryckebusch; Michèle Berthet; Dorothée Missé; Valérie Choumet
Journal:  Int J Mol Sci       Date:  2017-11-10       Impact factor: 5.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.